Literature DB >> 29986202

Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype.

Kazuyuki Saito1, Shuta Toru1, Sayuri Shima2, Tatsuro Mutoh3.   

Abstract

We herein report the first combined central and peripheral demyelination (CCPD) case originally diagnosed as multifocal acquired demyelinating sensory and motor neuropathy followed by CNS impairments with a long lag time (160 days after first attack). The anti-neutral glycolipids antibodies, especially anti-lactosylceramide antibodies but not anti-NF155 antibodies typical for CCPD were detected in the acute phase of sera and cerebrospinal fluid (CSF) and disappeared in the recovery phase. This case strongly illustrated the significance of examining anti-neutral glycolipids antibodies in future anti-NF 155 antibodies-negative CCPD cases.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-neurofascin 155 antibodies; Anti-neutral glycolipids antibodies; Chronic inflammatory demyelinating polyradiculoneuropathy; Combined central and peripheral demyelination; Encephalomyeloradiculoneuropathy

Mesh:

Substances:

Year:  2018        PMID: 29986202     DOI: 10.1016/j.clineuro.2018.06.046

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  1 in total

1.  The first pediatric anti-lactosylceramide antibody-positive encephalomyeloradiculoneuropathy.

Authors:  Akiko Sasaki; Itaru Hayakawa; Tatsuro Mutoh; Yuichi Abe
Journal:  Heliyon       Date:  2022-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.